Tao et al. demonstrated that Lysophosphatidylcholine acyltransferase 1 (LPCAT1) reprograms tumor cells cholesterol metabolism in esophageal cancer and could be applied as a potential treatment target against esophageal carcinoma [39]. The gene discussed is LPCAT1; the disease is esophageal cancer.